Author

Caryn Peterson

Institution: Gossamer Bio (United States)

Observed institution: Gossamer Bio (United States)

OpenAlex ID: A5076222747

Trial in Progress: A Phase 1b/2 Study of GB5121, a Brain-Penetrant, Potent, Highly Selective, and Irreversible BTK Inhibitor for Relapsed/Refractory Primary/Secondary CNS Lymphoma and Primary Vitreoretinal Lymphoma

2022 · Carole Soussain, Samar Issa, et al. · Blood · 1

Clrm-15 Trial in Progress: a Phase 1b/2 Study of Gb5121, a Novel, Highly Selective, Potent, and Cns-penetrant Inhibitor of Bruton’s Tyrosine Kinase (btki) for Relapsed/refractory Primary/secondary Cns Lymphoma (r/r Pcnsl/scnsl) and Primary Vitreoretinal Lymphoma (pvrl)

2022 · Carole Soussain, Christian Grommes, et al. · Neuro-Oncology Advances

Works count: 2

Citation count: 1

H-index: 1

I10-index: